Safety and Effectiveness Study of the Zenflow Spring System
NCT04987138 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 279
Last updated 2024-04-11
Summary
Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.
Conditions
- BPH (Benign Prostatic Hyperplasia)
- Lower Urinary Tract Symptoms (LUTS)
Interventions
- DEVICE
-
Zenflow Spring System
The Zenflow Spring Implant is an electropolished and passivated nickel titanium alloy (nitinol) implant. The implant is constructed from a single wire strand formed into ring elements connected by spine sections. There are four sizes of implants ranging from 16 mm to 24 mm in length and 14 mm to 16 mm in diameter to implant in the subject's prostatic urethra. The implant is placed in the urethra using a custom delivery catheter and cystoscope (Spring Scope). The implant is intended to be permanent but can be removed if necessary.
- DEVICE
-
Sham Procedure
A18 Fr Foley Catheter is placed into the patient's bladder. To mimic the Treatment Arm procedure, the Foley Catheter balloon will be inflated in the bladder. Once inflated, slight tension will be applied against the subject's bladder neck. While tension is being applied the site staff will follow a script to simulate the Zenflow procedural steps. Additionally, devices will be used to produce mock deployment sounds of the Zenflow procedure. Once complete, the balloon will be deflated and the catheter will be removed, completing the procedure.
Sponsors & Collaborators
-
Zenflow, Inc.
lead INDUSTRY
Principal Investigators
-
Claus Roehrborn, M.D · UT Southwestern, Dallas, TX
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-30
- Primary Completion
- 2024-06-30
- Completion
- 2026-06-30
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres
NCT03052049 ·Status: COMPLETED ·Phase: NA
-
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
NCT04987892 ·Status: RECRUITING ·Phase: PHASE4
-
RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up
NCT05784558 ·Status: WITHDRAWN
-
A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia
NCT01387893 ·Status: COMPLETED ·Phase: NA
-
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
NCT02592473 ·Status: UNKNOWN ·Phase: NA
-
Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
NCT06051383 ·Status: COMPLETED ·Phase: NA
-
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
NCT02026908 ·Status: COMPLETED ·Phase: NA
-
Study of Median Lobe Prostatic UroLift Procedure
NCT02625545 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate)
NCT01912339 ·Status: COMPLETED ·Phase: NA
-
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
NCT01457573 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NCT05757687 ·Status: RECRUITING ·Phase: NA
-
RT-310 Dose Escalation BPH Study
NCT06136819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms
NCT02245490 ·Status: COMPLETED ·Phase: PHASE4
-
UroLift System With SAbR for Prostate Cancer and BPH
NCT05311527 ·Status: COMPLETED ·Phase: NA
-
Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT02930889 ·Status: COMPLETED ·Phase: NA
-
Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients
NCT01736033 ·Status: UNKNOWN ·Phase: PHASE4
-
Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
NCT05201131 ·Status: RECRUITING
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Real World Data on Management of Male LUTS
NCT03075449 ·Status: COMPLETED
-
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy
NCT02961114 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
BE Technologies Mobile Uroflowmetry Validation Study
NCT04599283 ·Status: COMPLETED ·Phase: NA
-
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NCT05508165 ·Status: RECRUITING ·Phase: NA
-
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NCT04838769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia
NCT02054013 ·Status: COMPLETED ·Phase: NA
-
Ultrasound-Guided Photoselective Vaporization of the Prostate
NCT02346500 ·Status: COMPLETED ·Phase: EARLY_PHASE1